Todd Hockemeyer, CEO- Isotopia USA

We are thrilled to announce our plans to establish a cutting-edge isotopes manufacturing site in the USA. 

Our goal is to provide GMP-grade Lu-177 n.c.a. to our valued customers by 2024.
The state-of-the-art facility will feature production clean rooms, advanced analytical and microbiology laboratories, precursor isotope recycling systems, and radioactive waste management.
We are committed to delivering high-quality isotopes while prioritizing safety and sustainability
This milestone marks a significant step forward in our mission to advance nuclear medicine and improve patient care. 
Stay tuned for more updates as we embark on this exciting journey!

Read the full article:

More To Explore